ESTA

Establishment Labs Holdings Inc. (NASDAQ:ESTA) is a Costa Rica-based medical technology company founded in 2004 that specializes in manufacturing and marketing medical devices for aesthetic and reconstructive plastic surgery. The company went public in July 2018 and has grown from a regional player to a global manufacturer with operations across Europe, Latin America, Asia-Pacific, and most recently the United States. Under the leadership of founder Juan José Chacón-Quirós, who recently transitioned from CEO to Chief Evangelist, the company has positioned itself as an innovator in the breast implant market with its flagship Motiva Implants brand and emerging Mia Femtech minimally invasive platform.